Bitos Konstantinos, Müller Julian, Omuralieva Adilet, Schneider Simon R, Lichtblau Mona, Saxer Stéphanie, Tanner Felix C, Furian Michael, Mademilov Maamed, Sooronbaev Talant, Bloch Konrad E, Ulrich Silvia
Department of Cardiology, University Hospital of Zurich, Raemistrasse 100, Zurich 8091, Switzerland.
Department of Pulmonology, University Hospital of Zurich, Raemistrasse 100, Zurich 8091, Switzerland.
Eur Heart J Open. 2025 Mar 4;5(2):oeaf017. doi: 10.1093/ehjopen/oeaf017. eCollection 2025 Mar.
Patients with chronic obstructive pulmonary disease experience an increase in systolic pulmonary artery pressure (sPAP) when exposed to high altitude with an unclear acclimatization. We investigated the effects of acute ascent to 3100 m on pulmonary haemodynamics of patients with chronic obstructive pulmonary disease and their acclimatization during a 3-day stay at high altitude.
In this prospective, interventional study, stable, normocapnic patients with chronic obstructive pulmonary disease, with FEV 40-80%predicted and SpO ≥ 92%, residing at low altitude and staying for 3 days/nights at 3100 m without adverse events, were included. Echocardiography was performed at 760 m, directly after arrival at 3100 m (HA1) and the two following days (HA2/HA3). The primary outcome was the change in sPAP at different time points. Additionally, cardiac output (CO), tricuspid annular plane systolic excursion (TAPSE), and other echocardiographic parameters were measured. Thirty-eight patients with chronic obstructive pulmonary disease (37% females), aged (mean ± SD) 55 ± 10years, with FEV 63 ± 12%predicted, were included. After acute ascent to 3100 m vs. 760 m, sPAP increased by 12 mmHg [95% confidence interval (CI): 9-15, < 0.001], total pulmonary resistance (sPAP/CO) increased by 2 WU (1-3, = 0.001), and TAPSE/sPAP decreased by -0.6 mm/mmHg (-0.9 to -0.2, = 0.002). Right atrial pressure and CO were unchanged. At HA3 compared to HA1, sPAP decreased by -4 mmHg (-7 to -1, = 0.008); no significant changes in further echocardiographic parameters were observed.
In stable patients with chronic obstructive pulmonary disease travelling to and staying at 3100 m for 3 days/nights without adverse events, sPAP initially increased, along with an increased pulmonary resistance and a reduced right ventricular-arterial coupling reflected by a lower TAPSE/sPAP. Whereas sPAP steadily decreased during acclimatization, other echocardiographic parameters remained unchanged.
慢性阻塞性肺疾病患者在暴露于高海拔环境时,其收缩期肺动脉压(sPAP)会升高,但其适应过程尚不清楚。我们研究了急性上升至3100米对慢性阻塞性肺疾病患者肺血流动力学的影响以及他们在高海拔停留3天期间的适应情况。
在这项前瞻性干预研究中,纳入了居住在低海拔地区、稳定、正常碳酸血症的慢性阻塞性肺疾病患者,其FEV为预测值的40 - 80%,SpO₂≥92%,在3100米处停留3天/晚且无不良事件发生。在海拔760米处、到达3100米后即刻(HA1)以及随后两天(HA2/HA3)进行超声心动图检查。主要结局是不同时间点sPAP的变化。此外,还测量了心输出量(CO)、三尖瓣环平面收缩期位移(TAPSE)和其他超声心动图参数。纳入了38例慢性阻塞性肺疾病患者(女性占37%),年龄(均值±标准差)为55±10岁,FEV为预测值的63±12%。与海拔760米相比,急性上升至3100米后,sPAP升高了12 mmHg [95%置信区间(CI):9 - 15,P < 0.001],总肺阻力(sPAP/CO)升高了2 WU(1 - 3,P = 0.001),TAPSE/sPAP降低了 - 0.6 mm/mmHg(- 0.9至 - 0.2,P = 0.002)。右心房压力和CO无变化。与HA1相比,HA3时sPAP降低了 - 4 mmHg(- 7至 - 1,P = 0.008);未观察到其他超声心动图参数有显著变化。
对于前往3100米并停留3天/晚且无不良事件发生的稳定慢性阻塞性肺疾病患者,sPAP最初会升高,同时肺阻力增加,右心室 - 动脉耦联降低,表现为TAPSE/sPAP降低。而在适应过程中sPAP稳步下降,其他超声心动图参数保持不变。